Implanet SA (IMPZY)
0.08
0.00 (0.00%)
USD |
OTCM |
May 23, 16:00
Implanet Shareholders Equity (Quarterly): -0.1923M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.1923M |
June 30, 2023 | 4.644M |
June 30, 2023 | 4.644M |
December 31, 2022 | 3.797M |
June 30, 2022 | 2.625M |
June 30, 2022 | 2.625M |
December 31, 2021 | 3.175M |
June 30, 2021 | 1.261M |
June 30, 2021 | 1.261M |
December 31, 2020 | 1.257M |
June 30, 2020 | 1.170M |
June 30, 2020 | 1.170M |
December 31, 2019 | 1.609M |
June 30, 2019 | 2.169M |
June 30, 2019 | 2.169M |
December 31, 2018 | 2.749M |
Date | Value |
---|---|
June 30, 2018 | 4.936M |
June 30, 2018 | 4.936M |
December 31, 2017 | 7.544M |
June 30, 2017 | 7.755M |
June 30, 2017 | 7.755M |
December 31, 2016 | 10.21M |
June 30, 2016 | 7.183M |
June 30, 2016 | 7.183M |
December 31, 2015 | 10.63M |
June 30, 2015 | 14.34M |
June 30, 2015 | 14.34M |
December 31, 2014 | 8.772M |
June 30, 2014 | 14.73M |
June 30, 2014 | 14.73M |
December 31, 2013 | 19.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.1923M
Minimum
Dec 2023
4.644M
Maximum
Jun 2023
2.226M
Average
2.169M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
DBV Technologies SA | 111.65M |
Cellectis SA | 84.70M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 75.11M |
Innate Pharma SA | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.76M |
Total Liabilities (Quarterly) | 11.95M |
Debt to Equity Ratio | -31.75 |
Current Ratio | 0.7148 |
Net Debt Paydown Yield | 0.79% |